Pre-Op Weight Loss Improves Bariatric Surgery Outcomes
|
By HospiMedica International staff writers Posted on 25 Apr 2018 |

Image: A new study shows losing weight before bariartic surgery improves surgical outcomes (Photo courtesy of 123RF).
Patients who lost at least 8% of their excess weight through a low-calorie diet (LCD) immediately before bariatric surgery have more successful long-term outcomes, according to a new study.
Researchers at the Greenville Health System (GHS; Greenville, SC, USA) conducted a study to determine the effect of preoperative excess weight loss (EWL) on postoperative outcomes in 355 patients undergoing primary vertical sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2014 and 2016. The LCD included 1,200 kcal/day (45% carbohydrates, 35% protein, 20% fat), which were consumed through five meal-replacement products and one food-based meal. All patients were also instructed to conduct 30 minutes of moderate to vigorous activity per day.
The LCD was observed for four weeks immediately preceding surgery. The patients were then divided into two cohorts and analyzed according to those who achieved an 8% or higher EWL (224 patients), and those who did not (131 patients). The primary endpoints included percent excess weight loss (% EWL) at 1, 3, 6, and 12 months postoperatively. The results revealed that patients who achieved an 8% or higher EWL were more successful at continued weight loss during the first year after surgery than the patients who did not lose as much weight preoperatively.
The cohort that achieved the target contained a greater proportion of men than did the other group (25.5% vs. 13.7%, respectively), a higher proportion of white patients (84.8% vs. 74.1%), and a higher proportion of patients taking antihypertensive medications (68.3% vs. 57.3%). The two groups had similar rates of preoperative comorbidities and surgery types. In addition, those who achieved the target weight loss had a shorter hospital stay and a higher % EWL at three months, six months, and one year post-operatively. The study was published in the April 2018 issue of the Journal of the American College of Surgeons (JACS).
“These findings suggest that surgeons and clinical care teams should encourage healthy eating and exercise. The program helped patients establish healthy eating habits, establish portion control and learn what a healthy meal looks like,” said lead author clinical nutrition specialist Deborah Hutcheon, DCN. “Weight loss from the liver and abdominal cavity helps to improve surgical access, which may be why surgical times and recovery periods went down.”
“We call it the honeymoon period of bariatric surgery. After a year or year and a half, your body starts to figure out what it can and can’t do, and your behaviors may change a little bit, so the odds that you are going to lose a significant amount of weight after that time period are definitely decreased,” said senior author John Scott, MD. “Therefore, the more weight you can lose during that honeymoon period, the better, because that effort will help establish a set point, in terms of where your steady weight is going to be further down the road.”
Related Links:
Greenville Health System
Researchers at the Greenville Health System (GHS; Greenville, SC, USA) conducted a study to determine the effect of preoperative excess weight loss (EWL) on postoperative outcomes in 355 patients undergoing primary vertical sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2014 and 2016. The LCD included 1,200 kcal/day (45% carbohydrates, 35% protein, 20% fat), which were consumed through five meal-replacement products and one food-based meal. All patients were also instructed to conduct 30 minutes of moderate to vigorous activity per day.
The LCD was observed for four weeks immediately preceding surgery. The patients were then divided into two cohorts and analyzed according to those who achieved an 8% or higher EWL (224 patients), and those who did not (131 patients). The primary endpoints included percent excess weight loss (% EWL) at 1, 3, 6, and 12 months postoperatively. The results revealed that patients who achieved an 8% or higher EWL were more successful at continued weight loss during the first year after surgery than the patients who did not lose as much weight preoperatively.
The cohort that achieved the target contained a greater proportion of men than did the other group (25.5% vs. 13.7%, respectively), a higher proportion of white patients (84.8% vs. 74.1%), and a higher proportion of patients taking antihypertensive medications (68.3% vs. 57.3%). The two groups had similar rates of preoperative comorbidities and surgery types. In addition, those who achieved the target weight loss had a shorter hospital stay and a higher % EWL at three months, six months, and one year post-operatively. The study was published in the April 2018 issue of the Journal of the American College of Surgeons (JACS).
“These findings suggest that surgeons and clinical care teams should encourage healthy eating and exercise. The program helped patients establish healthy eating habits, establish portion control and learn what a healthy meal looks like,” said lead author clinical nutrition specialist Deborah Hutcheon, DCN. “Weight loss from the liver and abdominal cavity helps to improve surgical access, which may be why surgical times and recovery periods went down.”
“We call it the honeymoon period of bariatric surgery. After a year or year and a half, your body starts to figure out what it can and can’t do, and your behaviors may change a little bit, so the odds that you are going to lose a significant amount of weight after that time period are definitely decreased,” said senior author John Scott, MD. “Therefore, the more weight you can lose during that honeymoon period, the better, because that effort will help establish a set point, in terms of where your steady weight is going to be further down the road.”
Related Links:
Greenville Health System
Latest Surgical Techniques News
- FDA Approval Expands Bridging Stent Use in Complex Aortic Aneurysm Repair
- New Beam Measurement Approach Could Support More Precise Ion Therapy
- Tiny Robots Could Speed Targeted Drug Delivery to Heart Infections
- Contact Radiotherapy Offers New Organ-Preserving Approach for Rectal Cancer
- FDA Clears Antibiotic-Delivering Spacer for Infected Knee Replacements
- Vascular Occlusion System Gains Expanded FDA Indication for Venous Embolization
- Covered Stent System Achieves High Nine-Month Patency in Iliac Artery Disease
- New Heart Recovery Approach May Broaden Pediatric Transplant Donor Pool
- Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers
- Injectable Foam Dressing Conforms to Deep Traumatic Wounds and Inhibits Bacteria
- Magnetically Guided Capsule Enables Targeted Small Intestine Microbiome Sampling
- New FDA-Approved Pediatric Pulmonary Valve Can Expand as Children Grow
- New Software Tools Support Precision Mapping and Guidance in Cardiac Ablation
- PSMA PET/CT Imaging Guides Treatment Selection in Recurrent Prostate Cancer
- First Surgery Using Commercial Stem Cell-Derived Heart Muscle Sheets Performed in Japan
- Tile-Based Radiation Therapy Reduces Recurrence Risk After Brain Metastasis Surgery
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreCritical Care
view channel
Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read more
Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening
Obstructive sleep apnea occurs when the upper airway becomes blocked during sleep, repeatedly stopping or restricting breathing. The disorder often goes undiagnosed, leaving untreated individuals at increased... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease
Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more
Privacy-Preserving Learning Model Adapts Adult Radiology AI for Neonatal Care
Artificial intelligence models may support radiology image interpretation, yet pediatric and neonatal care remain underserved. Privacy restrictions limit access to children’s medical records, and pediatric... Read more
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read moreWorld Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more







